Technology: lowering the risk of error

In the coming years, HMR’s medical biology labs will see a 40% to 100% increase in demand depending on the area of activity.

To meet that demand and improve the labs’ performance, they have purchased a next-generation sequencing platform thanks to the HMR Foundation. The platform has an ultra-advanced computerized analytical capacity that makes it possible to establish fast, effective and more complete diagnoses at a lower cost, yielding estimated savings of $75,000 a year. This technology has a notable impact on the quality of analyses conducted by reducing the risk of error and, subsequently, complications for patients.